Stockscreener 앱 받기
0.52%
시장 영업 전:
Cigna Group 주식(CI)의 최신 뉴스
These 15 Connecticut-based companies made the 2025 Fortune 500 list of largest U.S. corporations - CT Insider
The Cigna Group (CI) Appoints Michael J. Hennigan as Independent Board Member - GuruFocus
Cigna Appoints Michael J. Hennigan to Board - TipRanks
Cigna Group adds Michael Hennigan to its board By Investing.com - Investing.com India
The Cigna Group Announces Appointment Of Michael J. Hennigan To Board Of Directors - marketscreener.com
The Cigna Group Announces Appointment of Michael J. Hennigan to Board of Directors | CI Stock News - GuruFocus
Marathon Petroleum's Executive Chair Brings Energy Sector Expertise to Cigna Group's Board - Stock Titan
Here's Why You Should Hold Cigna Stock in Your Portfolio for Now - sharewise
Cigna Group (CI) Target Price Raised by Barclays | CI Stock News - GuruFocus
Cigna (CI) Faces Potential Earnings Challenges Amid Analyst Concerns | CI Stock News - GuruFocus
Barclays Adjusts Price Target on Cigna Group to $385 From $382, Maintains Overweight Rating - marketscreener.com
Here's How Much $100 Invested In Cigna Group 15 Years Ago Would Be Worth TodayCigna Group (NYSE:CI) - Benzinga
The Cigna Group Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Cigna, CVS sue to block Arkansas' PBM regulation - HealthExec
Ex-Dividend Reminder: The Cigna Group, Macerich and Live Oak Bancshares - Nasdaq
CVS Health, Cigna sue Arkansas over PBM law (CVS:NYSE) - Seeking Alpha
Experts offer strategies to boost cognitive agility in the workplace - Cigna Healthcare Newsroom
The Cigna Group (CI): A Bull Case Theory - Insider Monkey
Express Scripts sues to block Arkansas law barring PBM ownership of pharmacies - marketscreener.com
Cigna Health Insurance Review 2025 - Forbes
Express Scripts sues Arkansas over new PBM law - Talk Business & Politics
Cigna study: High health insurance literacy associated with improved vitality, work productivity, and health outcomes - The Business Journals
The Cigna Group (NYSE:CI) Passed Our Checks, And It's About To Pay A US$1.51 Dividend - simplywall.st
Why You Might Be Interested In The Cigna Group (NYSE:CI) For Its Upcoming Dividend - Yahoo Finance
Personalized support for complex health care needs - Cigna Healthcare Newsroom
2 Reasons to Like CI and 1 to Stay Skeptical - FinancialContent
CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now? - Yahoo Finance
The Zacks Analyst Blog Highlights Costco Wholesale, Chubb, Cigna, Global Self Storage and Natural Health Trends - Yahoo Finance
Cigna’s SWOT analysis: stock poised for growth amid healthcare challenges - Investing.com
UBS Maintains Buy Rating on Cigna (CI) Stock - MSN
Molson Coors and Cigna Head My “Do Nothing” Stock List - TribLIVE.com
UBS maintains Cigna stock Buy rating with $390 target - Investing.com
Top Research Reports for Costco, Chubb & Cigna - Yahoo Finance
Guggenheim Reiterates Buy Rating for Cigna Group (CI) with $388 Price Target | CI Stock News - GuruFocus
Cigna Adds Kerecis Intact Fish-Skin Grafts to Coverage Policy - Business Wire
Cigna's (CI) Evernorth Secures Open Access for Key Products | CI Stock News - GuruFocus
Cigna Announced a New Agreement for Copay Caps on Eli Lilly and Novo Nordisk Weight Loss Drugs - MSN
FTC Scraps PepsiCo Price Discrimination Case In 3-0 Vote, Marking Major Shift As Trump-Era Leadership Reverses Biden CrackdownCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Cigna is putting a cap on weight loss drug costs - Yahoo Finance
Cigna (CI) Caps Out-of-Pocket Costs on Weight-Loss Drugs for Pat - GuruFocus
Cigna (CI) Caps Out-of-Pocket Costs on Weight-Loss Drugs for Patients | CI Stock News - GuruFocus
Cigna (CI) Expands Access to Weight Loss Medications with New Ph - GuruFocus
Cigna (CI) Unit Launches Cost-Effective Pharmacy Benefit for Wei - GuruFocus
Cigna (CI) Launches Cost-Effective Benefit Option for Weight Loss Drugs | CI Stock News - GuruFocus
Cigna (CI) Caps Weight-Loss Drug Costs, Impact on Telehealth Offerings | CI Stock News - GuruFocus
Former employees sue Cigna's 401(k) fiduciaries for misusing forfeited employer match money - Pensions & Investments
Pharmalittle: We're reading about rising drug prices, Cigna's plan for weight loss drugs, and more - statnews.com
Cigna to offer $200 Wegovy, Zepbound weight-loss benefit - Reuters
Cigna (CI) Launches Cost-Capping Program for Weight-Loss Drugs - GuruFocus
Cigna’s Evernorth caps weight-loss drug copays at $200/month (CI:NYSE) - Seeking Alpha
Cigna Offers New Weight-Loss Drug Pricing Plan to Boost Use - Bloomberg
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs - MSN
Cigna (CI) Faces Increased Scrutiny Amid Expanded Medicare Audits | CI Stock News - GuruFocus
Cigna Group's Evernorth Launches Benefit Option to Lower Weight Loss Medicine Costs - marketscreener.com
1.77%
자본화:
|
볼륨(24시간):